Related Experiment Video
Updated: May 10, 2026

Humanized NOD/SCID/IL2rγnull (hu-NSG) Mouse Model for HIV Replication and Latency Studies
Published on: January 7, 2019
Very late relapse after discontinuation of antiviral therapy for chronic hepatitis C
Vincent Soriano1, Eugenia Vispo, Carmen de Mendoza
1Department of Infectious Diseases, Hospital Carlos III, Madrid, Spain. vsoriano@dragonet.es.
Abstract:
Serum HCV RNA rebound beyond 24 weeks after completing hepatitis C therapy has been rarely reported. From 744 patients treated for chronic hepatitis C at our institution, 4 became HCV-RNA-positive again between weeks 36 and 48 post-treatment. Epidemiological and phylogenetic analyses supported very late HCV relapse instead of re-infection in two of them. This observation may have important implications in the pathogenesis and therapeutics of HCV infection.
Related Concept Videos
Hepatitis
Retrovirus Life Cycles
Viral Hepatitis I: Introduction
Cytomegalovirus Disease
Retroviruses
Size and Structure of Viral Genomes

